AI in Healthcare

Why did Novo Nordisk’s high-profile anti-inflammatory drug fail in phase 3, even after AI-assisted design? The answer isn’t in the data—it’s in the limits of what AI can predict. This failure, reported by STAT, highlights a critical flaw: AI can’t simulate the full complexity of human biology. As we build smarter models, we must also build smarter validation—where clinical intuition and mechanistic understanding guide, not just support, AI decisions. · Published November 08, 2026 https://www.statnews.com/2026/11/07/aha-2026-conference-novo-nordisk-zeus-trial-ziltivekimab-results/ Source: https://www.statnews.com/2026/11/07/aha-2026-conference-novo-nordisk-zeus-trial-ziltivekimab-results/ View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.